ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,929Medicare Part D Prescriptions Filled, Including Refills

Rank: 93 out of 680

$802K Total Retail Price of All Prescriptions

Rank: 133 out of 680

727 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 727 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 727 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 13,537 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 762 675 1 1
SIMVASTATIN 635 586 2 3
METFORMIN HCL 604 578 3 8
LEVOTHYROXINE SODIUM 589 532 4 2
LISINOPRIL 485 383 5 5
OMEPRAZOLE 438 374 6 7
HYDROCHLOROTHIAZIDE 420 359 7 9
HYDROCODONE-ACETAMINOPHEN 394 305 S3 8 4
PRAVASTATIN SODIUM 245 221 9 10
CITALOPRAM HBR 231 191 10 22
FUROSEMIDE 220 174 11 6
ATORVASTATIN CALCIUM 215 185 12 11
ATENOLOL 211 169 13 19
GABAPENTIN 210 162 14 15
ALPRAZOLAM 203 135 15 72
GLYBURIDE 202 185 R 16 85
METFORMIN HCL ER 191 175 17 54
METOPROLOL TARTRATE 189 173 18 12
NEXIUM 185 119 19 16
ZOLPIDEM TARTRATE 179 136 20 17
METOPROLOL SUCCINATE 178 134 21 13
AMOX TR-POTASSIUM CLAVULANATE 172 137 22 124
MELOXICAM 170 146 23 24
SERTRALINE HCL 157 131 24 28
PANTOPRAZOLE SODIUM 155 133 25 30
AMLODIPINE BESYLATE-BENAZEPRIL 152 136 26 43
FLUTICASONE PROPIONATE 152 104 26 41
POTASSIUM CHLORIDE 151 130 28 14
BENAZEPRIL HCL 145 135 29 40
SYNTHROID 144 130 30 38
CLOPIDOGREL 141 127 31 26
FENOFIBRATE 139 129 32 66
AZITHROMYCIN 138 119 33 42
TAMSULOSIN HCL 132 108 34 34
ESCITALOPRAM OXALATE 128 102 35 45
WARFARIN SODIUM 127 119 36 20
CLONIDINE HCL 119 111 37 36
PLAVIX 111 104 38 39
CIPROFLOXACIN HCL 110 88 39 57
CRESTOR 109 105 40 25
LEVOFLOXACIN 103 91 41 97
TRAMADOL HCL 102 94 42 18
ALENDRONATE SODIUM 97 97 43 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 94 80 44 37
LANTUS SOLOSTAR 84 67 45 84
INSULIN SYRINGE 80 53 46 86
VERAPAMIL ER 80 67 46 100
ADVAIR DISKUS 79 67 48 53
GLIMEPIRIDE 78 68 49 29
BYSTOLIC 78 67 49 79
PREMARIN 78 58 R 49 105
LOSARTAN POTASSIUM 77 77 52 21
DIOVAN 77 77 52 31
AMITRIPTYLINE HCL 77 71 R 52 47
JANUVIA 75 67 55 60
ALLOPURINOL 74 64 56 33
LOVASTATIN 74 72 56 44
MECLIZINE HCL 73 68 58 103
FELODIPINE ER 73 63 58 146
FLUOXETINE HCL 70 54 60 74
BISOPROLOL-HYDROCHLOROTHIAZIDE 69 67 61 156
LORAZEPAM 69 69 61 125
EXELON 68 68 63 112
LANTUS 67 50 64 49
VENLAFAXINE HCL ER 61 46 65 101
PROAIR HFA 59 37 66 67
LOSARTAN-HYDROCHLOROTHIAZIDE 59 59 66 51
NAMENDA 58 58 68 35
PAROXETINE HCL 55 45 69 76
DILTIAZEM 24HR ER 55 42 69 132
QUINAPRIL HCL 54 51 71 104
PREDNISONE 52 50 72 50
LEVEMIR FLEXPEN 52 45 72 186
BACLOFEN 52 42 72 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.